• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial 
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Centre for Cancer Prevention
    • Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Centre for Cancer Prevention
    • Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

    View/Open
    Published version (356.4Kb)
    Volume
    16
    Pagination
    67 - 75
    DOI
    10.1016/S1470-2045(14)71171-4
    Journal
    LANCET ONCOLOGY
    Issue
    1
    ISSN
    1470-2045
    Metadata
    Show full item record
    Authors
    Cuzick, J; Sestak, I; Cawthorn, S; Hamed, H; Holli, K; Howell, A; Forbes, JF; Investigators, IBIS-I
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/6566
    Collections
    • Centre for Cancer Prevention [857]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.